Overview
Anallely Rivas-Munoz practices in Mexico City, Mexico. Ms. Rivas-Munoz is rated as a Distinguished expert by MediFind in the treatment of ALG1-CDG. Her top areas of expertise are ALG1-CDG, PMM2-Congenital Disorder of Glycosylation, Childhood Acute Myeloid Leukemia, and Leukemia.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of ALG1-CDG.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALG1-CDGMs. Rivas-Munoz isDistinguished. Learn about ALG1-CDG.
- Experienced
- Childhood Acute Myeloid LeukemiaMs. Rivas-Munoz isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaMs. Rivas-Munoz isExperienced. Learn about Leukemia.
- PMM2-Congenital Disorder of GlycosylationMs. Rivas-Munoz isExperienced. Learn about PMM2-Congenital Disorder of Glycosylation.